Markers of apoptosis in stage IB squamous cervical carcinoma

Journal of Clinical Pathology

Volumn 58, Issue 6, 2005, Pages 590-594

  Van De Putte, G ^a   Holm, R ^a   Lie, A K ^a   Baekelandt, M ^a   Kristensen, G B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL;

ADULT; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ADULT; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CARCINOMA, SQUAMOUS CELL; CYTOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 20444465767     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.021220     Document Type: Article

References (32)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
2. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-2.
3. Tsujimoto Y, Finger LR, Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t (14; 18) chromosome translocation. Science 1984;226:1097-9.
4. White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996;10:1-15.
5. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993;81:151-7.
6. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
7. Jurgensmeier JM, Xie Z, Deveraux Q, et al. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A 1998;95:4997-5002.
8. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
9. Findley HW, Gu L, Yeager AM, et al. Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 1997;89:2986-93.
10. Park JR, Bernstein ID, Hockenbery DM. Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood 1995;86:868-76.
11. Ma A, Pena JC, Chang B, et al. Bclx regulates the survival of double-positive thymocytes. Proc Natl Acad Sci U S A 1995;92:4763-7.
12. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
13. Benedet JL, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri. J Epidemiol Biostat 2001;6:7-43.
14. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
15. Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol 1999;73:177-83.
16. Poulsen HE, Taylor CW, Sobin LH. Histological typing of female genital tract tumours, International histological classification of tumours. Geneva: World Health Organisation, 1975.
17. Tjalma W, Weyler J, Goovaerts G, et al. Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix. J Clin Pathol 1997;50:33-6.
18. van de Putte G, Holm R, Lie AK, et al. Expression of p27, p21 and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol 2003;89:140-7.
19. Graflund M, Sorbe B, Karlsson M. Immunohistochemical expression of p53, bcl-2, and p21 (WAF1/CIP1) in early cervical carcinoma: correlation with clinical outcome. Int J Gynecol Cancer 2002;12:290-8.
20. Jain D, Srinivasan R, Patel FD, et al. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treqted by radiotherapy. Gynecol Oncol 2003;88:22-8.
21. Uehara T, Kuwashima Y, Izumo T, et al. Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome. Eur J Gynaecol Oncol 1995;16:453-60.
22. Dimitrakakis C, Kymionis G, Diakomanolis E, et al. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol Oncol 2000;77:129-36.
23. Saegusa M, Takano Y, Hashimura M, et al. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer 1995;76:2297-303.
24. Crawford RA, Caldwell C, Iles RK, et al. Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer. Br J Cancer 1998;78:210-14.
25. Pillai MR, Jayaprakash PG, Nair MK. Bcl-2 immunoreactivity but not p53 accumulation associated with tumour response to radiotherapy in cervical carcinoma. J Cancer Res Clin Oncol 1999;125:55-60.
26. Rajkumar T, Rajan S, Baruah RK, et al. Prognostic significance of Bcl-2 and p53 protein expression in stage NB and IIIB squamous cell carcinoma of the cervix. Eur J Gynaecol Oncol 1998;19:556-60.
27. Chung TK, Cheung TH, Lo WK, et al. Expression of apoptotic regulators and their significance in cervical cancer. Cancer Lett 2002;180:63-8.
28. Ferrandina G, Mozzetti S, Marone M, et al. Bcl-2, bax, bcl-x(L) and bcl-x(S) expression in neoplastic and normal cervical tissue. Cancer Lett 2000;155:19-27.
29. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000;19:453-73.
30. Mozzetti S, Ferrandina G, Marone M, et al. Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues. Cancer Defect Prev 2000;24:536-41.
31. Tjalma WA, Weyler JJ, Bogers JJ, et al. The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 2001;97:223-30.
32. Paxton JR, Bolger BS, Armour A, et al. Apoptosis in cervical squamous carcinoma: predictive value for survival following radiotherapy. J Clin Pathol 2000;53:197-200.